Question 1

Does NewEdge Advisors own AKTX stock?

Accepted Answer

No. NewEdge Advisors exited its AKTX (Akari Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 6,800 shares worth $1,965.

Question 2

How many shares of AKTX does NewEdge Advisors own?

Accepted Answer

None since Q1 2026, when NewEdge Advisors exited the position. Its Q4 2025 13F listed 6,800 shares worth $1,965.

Question 3

What is NewEdge Advisors' AKTX position worth?

Accepted Answer

NewEdge Advisors' AKTX position was worth $1,965 in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is NewEdge Advisors buying or selling AKTX?

Accepted Answer

In Q1 2026, NewEdge Advisors exited its entire AKTX position.

Question 5

When did NewEdge Advisors first buy AKTX?

Accepted Answer

NewEdge Advisors first reported AKTX in its Q2 2025 13F and listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$5.15	0
2025-Q4	Unchanged	6,800	0.0%	$1,965	0.0%	$11.56	0
2025-Q3	Unchanged	6,800	0.0%	$6,868	0.0%	$40.40	0
2025-Q2	New	6,800	—	$7,955	0.0%	$46.80	25